Interactions between Cancer and Bone Marrow Cells Induce Osteoclast Differentiation Factor Expression and Osteoclast-like Cell Formation in Vitro
- 19 January 2000
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 267 (2), 632-637
- https://doi.org/10.1006/bbrc.1999.2008
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Vehicle Racing Commemorative Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal CellsEndocrinology, 1998
- Mouse Mammary Carcinoma Cell Line (BALB/c-MC) Stimulates Osteoclast Formation From Mouse Bone Marrow Cells Through Cell-to-Cell ContactBone, 1998
- Suppression of Interleukin-11-mediated bone resorption by cyclooxygenases inhibitorsJournal of Cellular Physiology, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998
- The Mouse Mammary Tumor Cell Line, MMT060562, Produces Prostaglandin E2 and Leukemia Inhibitory Factor and Supports Osteoclast Formation In Vitro Via a Stromal Cell–Dependent PathwayJournal of Bone and Mineral Research, 1998
- Parathyroid hormone-related protein and bone metastasesCancer, 1997
- Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Bone resorption induced by a metastatic human melanoma cell lineBone, 1995